Gilead's remdesivir gets U.S. FDA approval for hospitalized COVID-19 patients - Reuters India

2:23pm PDT - October 22nd, 2020    veterans day - Reuters

The U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc's antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease in the United States.